Investing.com
Published Mar 12, 2025 05:50PM ET
Ascend Wellness Holdings Inc. (AAWH) reported its fourth-quarter 2024 earnings on March 12, revealing an unexpected earnings per share (EPS) beat. The company posted an actual EPS of -0.08, surpassing the forecast of -0.10. Despite this, revenue fell short of expectations, coming in at 136 million dollars against a forecast of 140.19 million dollars. The stock reacted positively, with a 3.33% increase in after-hours trading, closing at 0.31 dollars. According to InvestingPro analysis reveals the stock has experienced significant volatility, with a beta of 1.63 and a steep 70.75% decline over the past year. Discover detailed technical analysis and more insights with an InvestingPro subscription.
Ascend Wellness plans to expand its store base by approximately 50% in 2025, with 10 new locations already identified. The company expects to maintain an adjusted EBITDA margin above 20% and anticipates top-line and margin gains in the second half of 2025. Capital expenditures for 2025 are projected to be between 30 and 35 million dollars.
Frank Perullo, President of Ascend Wellness, emphasized operational improvements, stating, "We are running our business better as evidenced by our improvements in profitability." CEO Sam Brill highlighted the company's strong financial position, noting, "We're fortunate to have a very healthy balance sheet with a large cash balance, where we could take advantage of situations."
During the earnings call, analysts inquired about the strategic focus on retail expansion in Illinois and New Jersey. Management reiterated their careful approach to selecting store locations and competition. Additionally, the implementation of a share buyback program and efforts to improve cultivation yields were discussed.
Operator: Good afternoon, and thank you for standing by. Welcome to Ascent Wellness Holdings Fourth Quarter twenty twenty four Earnings Call. The presentation that accompanies this call can be found on the Investor Relations section of the company's website. Before proceeding, AWH would like to remind you that the following discussion and presentation contains various forward looking statements or information. These forward looking statements or information are subject to risks and uncertainties that may cause actual results to differ from historical or undiscivated results.
For more information on the risks and uncertainties, please refer to slide two of this presentation, today's earnings release and AWH SEC and SEDAR filings, including their most recent report on Form 10 ks. During today's call, the company will be referring to non GAAP financial measures such as adjusted EBITDA. Reconciliations to the most directly comparable GAAP measures are in appendix to the presentation and in the company's earnings release. On today's call, I am pleased to introduce Ascend's management team starting with Sam Brill, director and chief executive officer. Sam will provide an update on the company's key objectives and high level financial priorities.
Also on the call is Frank Perullo, Co Founder, Director and President. Frank will share updates on the company's operational plans and highlights from the quarter. And lastly, Roman Nemchenko, Chief Financial Officer, will review financial performance for the quarter. I'd now like to hand the conference over to your first speaker today, Samriel. Please go ahead.
Sam Brill, Director and Chief Executive Officer, Ascent Wellness Holdings: Thank you, operator, and thank you to everyone joining us on the line today. This was our first full quarter with a new management team in place and I'm incredibly proud of the work the entire team has done to support our key transformation initiatives and new strategic roadmap. Ascendant has the right assets in the right places in the right markets and now we're focused on how to best utilize those assets to drive profitability and sustainable cash flow generation. I'm very pleased to share that we've already seen faster than expected improvement in both our profitability and cash generation. More importantly, we installed a new mindset and culture around cost controls going forward.
Looking first at profitability, during the first quarter, we improved the adjusted EBITDA margin by four fifty basis points or $30,200,000 representing a sequential increase of 20.4%. This is largely due to our execution on the approximately $30,000,000 in annualized cost savings we identified, which has been substantially completed to date. We expect some of these savings to take a little longer to show up in cost of goods sold as we cycle out of higher cost inventory and add automation and other efficiencies to our facilities. As discussed last quarter, improving profitability remains our top goal and we believe there's still more opportunity to close the margin gap with our MSO peers. Next, we also exceeded our initial expectations for delivering on cash generation.
With fourth quarter cash from operations of 35,200,000 we have successfully achieved our eighth consecutive quarter of positive cash from operations and realized free cash flow of $30,100,000 for the quarter. This helped increase our cash and cash equivalents to $88,300,000 at the end of Q4 twenty twenty four. Lastly, we continue to implement our densification strategy and have identified a robust pipeline of opportunities as we focus on expanding our store base by approximately 50% or 20 locations in the midterm. We currently have 10 locations identified, which we expect will mostly come online throughout the second half of twenty twenty five. This includes three in Ohio, one in Pennsylvania, two partner sites identified in New Jersey, as well as four additional partner stores in Illinois, which would bring the total partners in the state to six.
While we're pleased with the improvements we've made during the quarter, the work is far from complete. Over the past couple of years, our organization has become overly focused on corporate priorities, losing sight of the most critical element of a retail and CPG business, the customer. Correcting this is an immediate priority for our team for entire team. To succeed, we must prioritize the needs and wants of our consumers and everything that we do. To that end, we've begun implementing a series of changes to our retail experience and we are refreshing our brands to help reinvigorate our top line.
Let's move to Slide five to discuss the key highlights from Q4. As previously mentioned, we substantially completed our $30,000,000 in annualized cost savings initiatives and implementing long term processes and controls. We also sustained our industry leading average revenue per store despite a challenging consumer environment that we operate on. This was our first full quarter of adult use sales in Ohio and the initial response from consumers has been great. Given the restrictive regulatory framework, we expect to see more growth in this market when advertising is allowed and additional form factors such as pre rolls are introduced later this year.
In addition, we launched Ethn, a brand focused on delivering targeted effects, which has been a significant success in wholesale and is the number one selling edible brand in our stores. For the first time in the company's history, we're buying back AWH shares. We view our shares as undervalued. So we believe there's no better time to return value to shareholders. To that end, we repurchased 11,000,000 shares of Class A common stock representing over 5% of the shares outstanding.
Furthermore, we announced the commencement of a share buyback program to repurchase for cancellation up to another $2,200,000 in stock, which began in January. Subsequent to the quarter end, we repurchased an additional 620,500 shares through this program. Turning now to Slide six, where I'll discuss the core strengths of the business going forward. Since taking on my new role at Ascend, I've had the opportunity to tour many of our facilities and retail stores and learned about the important assets we've amassed. Over the last two months, I went further and took the time to work alongside our talented team in cultivation, manufacturing and retail.
This experience allowed me to fully appreciate and understand their respective roles and has given me a better perspective on their insights. It allowed me to see firsthand what's working well and where we may face challenges ahead. This experience has helped me inform our decision to reinvigorate our customer centric approach. I'm truly grateful for the hard work and dedication of every member of our team as we continue to move forward together. Spending this time across our organization has deepened my perspective that Ascend really does stand out in the industry, thanks to our core strengths that I previously discussed on last quarter's call.
First off, we have a strong retail footprint with exceptional locations. We believe these strategically positioned storefronts will continue to give us an advantage as the industry evolves. The company continues to maintain its data back focus on premier locations and high density population centers. With more competition building, we expect that the retail locations will play a significant role in where customers choose to shop and we have some of the best locations in each of our states. Next, our customers continue to have a great experience when they visit as demonstrated by our excellent Net Promoter Score of over 70 at the enterprise level.
However, that does not always translate into repeat visits or strong ticket sizes. Therefore, we are developing new KPIs to help drive customer retention and average ticket. Frank will elaborate more on this shortly, but we are optimizing our interactive kiosks and online menus to enhance the consumer experience by making it easier for them to find what they want and need. This superior experience also leads customers to choose our products and engage with our brands. Over the next few weeks, we plan to commercialize approximately three fifty refresh SKUs.
We can offer these highly popular products due to our strong cultivation and production capabilities. During Q4, our cultivation team delivered the highest ever network average grams per square foot, the highest network average potency and the most pounds we have ever harvested. Lastly, to ensure these products reach our customers, we've developed an outstanding and comprehensive distribution network that covers over 90% door share in each of our top two wholesale markets. Given our focus on driving margin growth, we have strategically evaluated our product portfolio with a focus on eliminating unprofitable SKUs and delinquent wholesale accounts. While this will have a short term impact on revenue, our efforts will help to build a stronger foundation that will set us up for long term success.
While we anticipate there will still be challenges ahead for both the industry and Ascend, I firmly believe that our key differentiators will empower us to succeed as we execute on our strategic goals for 2025. The opportunity for us is there and we are excited about Ascend's potential going forward. Now, I'll turn it over to Frank Perullo, President and Co Founder, who will discuss our key operational initiatives beginning on Slide eight.
Frank Perullo, Co-Founder, Director and President, Ascent Wellness Holdings: Thank you, Sam. Good afternoon, everyone. I am pleased to be here today to share an update on the assessments and actions we have performed and implemented across our organization to drive and strengthen our business. As Sam highlighted, we saw significant initial momentum following the implementation of our key transformation initiatives during the quarter. Simply put, we are running our business better as evidenced by our improvements in profitability.
We focused our assessments and actions on our people, processes and technology. In many cases resources needed to be allocated more effectively, tools implemented and processes were immature or we were gaps with a lack of process. We have made significant progress in all areas, but we'll be working on a roadmap of continuous improvement in all facets of the business. An example of the success I am particularly pleased with was the team's ability to positively impact working capital in the quarter for reducing gross spend and better inventory management across both channels of the business. We employed better tools, improved processes and allocated the resources needed to improve our inventory management and biomass routing at our manufacturing facilities.
That being said, competition is growing across our markets as they mature, which is leading to some top line revenue pressure, specifically in our core regions. While this presents challenges, it has reinforced our belief that our strong retail presence and wholesale capabilities will continue to drive our success as these markets mature. Operational excellence will be a key pillar of the roadmap to help deliver for our customers. We're focused on building our business for long term growth with an emphasis on delivering high quality products and an exceptional retail experience for patients and customers. The customer will be at the center of how we think and what we do every day at Ascent.
Let's first look at how we put the customer first in the retail business. Let's move to Slide nine. Q4 was only the second quarter in over three years that we did not add a new store. We finished 2024 with $372,200,000 in retail revenue, a 0.3% increase year over year. In the quarter, we achieved $90,400,000 in retail revenue.
A focus area in the quarter was to identify key retail opportunities to improve top line revenue margin, customer retention and acquisition strategies. A key focus for our team going forward is returning our organization to a customer first mentality. Our assessments targeted the fundamentals of retail, including having the right products and pricing while giving the customer the best experience. In the quarter, we worked to ensure we curated the right selection of products on our menus. We also had to sell through aging inventory and overstock SKUs in the quarter to bring our days on hand to optimal levels.
We worked to ensure we had well balanced menus to give the customers great AWH branded products and the top selling SKUs in each market. Having market by market planograms, in store and virtual, as well as more effectively utilizing market data on sell through and customer shopping habits are key initiatives to ensure we have the right products for our customers. We also focus the review on our buying org to ensure we always have the right products in stock at the right price and margin. Driving better deals for our customers will be key to our retail success as markets normalize. It also helps drive the right segmentation for AWH products in our stores where we want to be the best priced products in each category.
The work started to pay off as we achieved the highest level of AWH penetration in the quarter. During the quarter, we increased AWH penetration to 55%, a 6% increase quarter over quarter. AWH penetration is a key KPI to drive strong margins and keep our manufacturing facilities producing the units needed to drive down costs. In addition to ensuring we deliver an exceptional experience at our retail dispensaries, we are also focused on providing a similarly positive experience through our online capabilities. We are pleased to announce that in the quarter, we started the build in transition of our e commerce site letsascend.com to a new e commerce portal to transform the manner consumers engage with Ascend.
We're creating a more curated online shopping experience that offers a streamlined selection of products with an integrated loyalty program. The new e commerce portal will utilize AI and machine learning to help personalize each customer's experience. We will deliver a better online shopping experience for our customers, whichever manner they get their candidates. Delivery, curbside, in store, our new e commerce portal will be the one stop shop. The newest Send shopping experience will start to roll out to customers next week and will be in all markets by the summer.
In the quarter, we also reset our retail training programs for new and existing employees. The goal was to increase engagement and the level of service given to every customer from the moment they walk in and is greeted with welcome to Ascent. Ultimately, it's about the customer's journey and we're committed to ensuring that cost saving measures do not compromise the quality of the experiences we deliver. Lastly, as part of our retail densification strategy, we have identified potential partner locations in Illinois and New Jersey, which we expect to significantly ramp up store openings during the second half of twenty twenty five. In New Jersey specifically, we have the opportunity to develop up to seven partner locations.
We view this as a strong market for us and one where we can carefully hone our partnership approach, which can then be rolled out across additional markets. Our first New Jersey partner store located in Little Falls is on target to open early in Q2. We have two additional New Jersey partner stores in development to open later in 2025. This is in addition to our final PA store under our license as well as the three additional Ohio stores, all currently under development. Let's move to Slide 10 to discuss the operation and wholesale business.
In 2024, we sold a record number of pounds of wholesale products and increased wholesale revenue in each of the company's key markets compared to the prior year. In the quarter, we maintained or gained share in each of our key wholesale markets. Our cultivation and operations teams supported these wholesale milestones delivering record results across the network. During Q4, our cultivation team delivered the highest network average ever of grams per square foot, potency and the most palm harvested. These positive results helped drive increased production at our facilities to fuel both retail and wholesale channels.
During the quarter, we increased brand recognition across the portfolio in various markets with AWH brands being market leaders in all of the third party wholesale markets in which the company operates. Our Simply Herve brand remained the number one selling brand in Massachusetts. Ozone rose to the number one brand in units and number three brand in sales in New Jersey. Ozone also remained the number two brand in sales and number one in units in Illinois. Also in the quarter, we grew our brand portfolio.
With increased demand for our products as previously mentioned, we drove an increase in vertical sales of 6% in Q4 compared to Q3 twenty twenty four. Strong brands helped improve vertical sales, which will continue to drive asset efficiency and a larger share of our revenue from in house products. In turn, our CPG initiatives will further help enhance our margins. We introduced Efnan, a brand designed to deliver targeted effects using minor cannabinoids. The brand has been well received in all the markets where it's available and is a top performer in the edibles categories at our stores.
We plan to expand the Epson line in the coming weeks with additional targeted effects. Building upon this success, we are launching a new line of premium infused pre rolls, which will be available in all major markets this year. This expansion is expected to start rolling out later this month. This will help us meet the evolving demands of our customers ensuring that we continue to provide high quality innovative products. We are commercializing almost three fifty products across six markets during Q1 in all product categories, ensuring Ascend branded products are available to our customers however they consume.
While we are pleased with the early success of the changes implemented across the network, we have more work to do to continuously improve the people, process and tools servicing the business. Our assessment and review of our commercial and operations org helped to create a roadmap for 2025. The roadmap serves to stratify breadth and depth of production output to match our customer preferences. These actions should help stabilize production attainment and labor allowing us to steer the business to lower COGS and higher margin. A key initiative still in flight to help enable this progress is automation.
At our Athol Mass cultivation and manufacturing currently introducing automation and new equipment on several production lines, including pre rolls, flower pack and vape filling. The equipment and process changes happening right now in Athol will be used as a guide and proof of concept to increase efficiency, throughput and help lower our cost of goods. Increased automation can transform the ways which we produce our products, allowing us to scale operations more efficiently and fuel more product innovation such as our new infused pre roll on. As we prove and refine this approach, we expect we will see meaningful labor savings and improved efficiencies once we roll it out at scale across our footprint. We're also making targeted investments to improve yields and reduce variability, while ensuring this is done carefully to mitigate disruptions.
In conclusion, we closed out 2024 with several positive highlights, including the successful transition to out new sales in Ohio, the swift implementation of our cost saving initiatives and the strong performance of our latest brand launch. Q4 was the first full quarter of our refresh management team addressing our margin and profitability challenges. With these areas improving, we will continue to focus on the customer to guide the roadmap for 2025. We need to think like a customer and keep them at the center of all we do. I will now turn it over to Roman Nemchenko, our Chief Financial Officer.
Roman will discuss our financial performance and near term expectations.
Roman Nemchenko, Chief Financial Officer, Ascent Wellness Holdings: Thank you, Frank, and good afternoon, everyone. We're pleased to report that the company generated $562,000,000 in net revenue for the 2024 fiscal year. This represents a $43,000,000 dollars or an 8.3% increase year over year, primarily due to the expansion of our wholesale business. Adjusted gross profit also increased by $17,000,000 or 8.1% to a total of $226,000,000 and adjusted EBITDA increased by $10,000,000 or 9.4% to a total of $116,000,000 Revenue for the fourth quarter was $136,000,000 and down 4% sequentially. Of this decrease, 2.3% was due to retail sales and the remaining 1.7% was driven by wholesale.
Price compression in some of our core markets had the largest impact on both sales channels, leading to a decline in the average basket size quarter over quarter. We believe this is also consistent with trends reported by BDSA, as well as some of our peers with year end promotions and discounting driving average prices down. Fourth quarter adjusted EBITDA was $30,200,000 representing a 20% sequential improvement. This improvement was largely driven by 6.3% increase in adjusted gross profit margin as demand for a sand made product increased at our stores, improving our vertical sales and enabling us to realize higher margins during the period. The various reductions in operating costs discussed earlier and on our previous call further contributed to the improvements in adjusted EBITDA.
Let's now move on to the next slide to discuss cash and the balance sheet. Quarter over quarter, our cash increased by $23,000,000 to $88,300,000 as we generated $30,100,000 of free cash flows during the period. This net increase was mostly driven by operating cash flows of $35,000,000 offset by $7,000,000 used in investing and $5,000,000 used in financing activities. While the operating cash flows of $35,000,000 represents the eighth consecutive quarter of positive operating cash flows, it is also our all time high in a single quarter. This was mostly driven by improved utilization of working capital, reduction in operating costs, as well as approximately $10,000,000 of state income tax refunds received during the quarter.
Total investing cash outflows of $7,000,000 includes $5,000,000 of CapEx, of which $2,700,000 was for new store build outs. For 2025, we expect to invest approximately $30,000,000 to $35,000,000 in CapEx, roughly half of which would be for new store openings. Financing cash outflows includes approximately $2,700,000 used for the repurchase of common shares through a private transaction in December at a significant discount to the market. Although we've made significant strides during the first full quarter under the new management, we're still facing headwinds in our core markets from both internal and external factors. For Q1, we expect mid single digit percentage decline in revenue as consumer discretionary spending softens following the holiday season and weather related events, which impacted our retail sales in multiple markets.
Continued press compression and shorter quarter will add further pressure on the average basket size and ticket count. However, despite the expected near term softness in the top line, we expect to maintain our adjusted EBITDA margin above 20%. Looking further ahead, the top line as well as our margin should begin to show gains over the second half of the year.
Neil Gilmer, Analyst, Haywood Securities: We look
Roman Nemchenko, Chief Financial Officer, Ascent Wellness Holdings: forward to executing on our growth strategies with the same focus and attention as the cost savings initiatives implemented in Q4 and we'll provide updates on our progress during the next call. On behalf of the management team, I would now like to thank each of our team members for their dedication and efforts in getting us to this stage as well as investors and partners for their continued support. I will now turn it over to the operator for questions.
Operator: Thank you. Your first question comes from the line of Federico Gomez from ATB Capital Market. Please go ahead.
Federico Gomez, Analyst, ATB Capital Market: Hi, good evening. Congrats on the great quarter. Thanks for taking my questions. First question is on your retail expansion. So you are planning to expanding some of these competitive retail markets like Illinois and New Jersey.
So I'm curious how you look at those markets? What are you assuming as a base case scenario for those stores that you intend to open? Are you expecting a normalization of retail in those markets as they already close to saturation or do you assume continued pressures and that's already sort of baked into your strategy? Thanks.
Sam Brill, Director and Chief Executive Officer, Ascent Wellness Holdings: Hi, Frederico. Thanks for that question. So we see these two markets as our core markets, right? We want to increase that verticality. It's where we have the biggest fixed cost assets and we need to drive more volume through a bigger retail footprint.
The focus remains the same. We're being extremely picky about where what we're buying and where the locations of the stores are. The location as we stated before, we don't want to impact our footprint whatsoever. We want to improve that footprint. And so we're just looking for premier locations in key markets.
And we're going to stay disciplined to that as a number one. Number two, the store needs to be competitive. And we need to make sure that we see it as a less I would say less saturated location. So we're very careful about what the competition looks like, where we're located. And again, we know how the competitors in that market do because we're a huge wholesaler.
So we have that inside information to understand what the trajectory is in terms of their purchasing. So we know how things are going besides just doing the underwriting in each store. But like in all these situations, it's the price compression I think more so than a competition because again, if you're in good location, you have a good mousetrap because you're going to be able to keep those customers. But price compression is statewide in places like Illinois, so it's a lesser extent, New Jersey. But it's something that we take into account and that's where we're focused on the other side of the business, which is driving costs down in our cultivation and manufacturing facilities to stay ahead of that price curve.
I think your question was longer than that. So feel free to follow-up if I miss something.
Federico Gomez, Analyst, ATB Capital Market: No, that's perfect. I appreciate that color. That answers it. And I guess the second question on the just on the capital allocation, you've been active on the buyback. How do you look at the buyback?
And obviously, you have a pretty ambitious growth plan here. But at the same time, it is a challenging market with price compression and such. So how do you look at those options in terms of actually keeping the cash in the balance sheet for a rainy day and just using the cash to buy back stock or invest for growth? Thanks.
Sam Brill, Director and Chief Executive Officer, Ascent Wellness Holdings: No, good question. Look, we're fortunate to have a very healthy balance sheet with a large cash balance, where we could take advantage of situations. And the great thing is that we have a very robust pipeline of opportunities in terms of stores to buy in multiple markets. But we have the ability now to be, I think, a little picky about what we do, given that the supply demand dynamic is turned into our in our favor. So we're going to be very careful with that precious cash on our balance sheet.
But at the same time, we look at our shares where we're trading in terms of market cap relative to what we see in terms of the value of the business. And we think that that is an extremely attractive opportunity to return cash to shareholders in the form of shrinking our market cap. So we're trying to stay balanced and disciplined with that. And again, we don't lose sight of the fact that the cash is extremely important on this balance sheet and in this industry. So we're going to be very careful with that the shareholder cash.
Federico Gomez, Analyst, ATB Capital Market: Thanks for the color. I'll hop back in the queue.
Operator: Thank you. Your next question comes from the line of Neil Gilmer from Haywood Securities. Please go ahead.
Neil Gilmer, Analyst, Haywood Securities: Yes, good afternoon and thanks very much. I guess just want a little bit more color on the $30,000,000 savings that you said you've already implemented, which seems quick from my perspective, so it's a good thing. Can you remind us how much of that is sort of split between COGS and SG and A and sort of get a sense of how much of that we actually saw reflected in Q4 versus I know you said in the prepared remarks that not all of it has been there, but just trying to get a sense of how much more we should sort of be expecting to see reflected in that P and L throughout the course of 2025 here?
Sam Brill, Director and Chief Executive Officer, Ascent Wellness Holdings: Sure. So first of all, Neal, thank you for the question. About half of the annualized savings was in SG and A and reflected in that first full quarter. So we'll see the benefit of that as the year goes on. The other half is all in COGS and that will take a little longer as we implement the automation and other initiatives that we talked about on the call.
Neil Gilmer, Analyst, Haywood Securities: Okay. Thank you for that. I guess my follow-up would sort of go in towards the inventory comments in the call. We can see that decline in inventory that you realized in Q4. And I think the I'm trying to remember the exact where the prepared remarks was something along the lines of towards more normal levels.
So are you at a point now where you're comfortable with your inventory and this is where you're going to try to hold it to? Or do you feel there's still opportunities to reduce some day sales outstanding on that level?
Sam Brill, Director and Chief Executive Officer, Ascent Wellness Holdings: We're very proud. I mean, if there's one thing besides the cost savings that I'm super excited about and proud of is the way that we've really fixed our balance sheet. We made a lot of progress. We were just way overweight on inventory and we needed to rationalize that. We are in a business where we have products that have a certain shelf life, right?
These are perishable products and we have to think that way. So days of sales outstanding is a top, KPI that we track every day in every store and we make sure that we don't get out over our skis and we put it we've implemented processes to ensure that we don't end up in the same place. And we're also much smarter about how we're purchasing and how frequently we're purchasing and what we're purchasing. This whole customer centric initiative is all about that, curating that product for the customer, making sure that when they any store that they come into, they're going to have the most popular SKUs, not just ours. But those are have to be what we're carrying, not things that just are going to sit on the shelf.
We're going to end up having a discount and then that ends up competing against everything else we have on the menu. So it ends up driving down your basket size, your margin, everything. So that discipline is a top priority moving forward. But I think that's where we made the most significant progress that will have long term positive effects on the business.
Neil Gilmer, Analyst, Haywood Securities: Okay. Thanks very much. Appreciate it. We'll get back in queue.
Federico Gomez, Analyst, ATB Capital Market: Thank you.
Operator: Thank you. And your next question comes from the line of Andrew Sample from Vantum Financial. Please go ahead.
Andrew Sample, Analyst, Vantum Financial: Thank you. Congrats on the Q4 results. So first off, just on the cultivation yields hitting record highs. I believe I caught in
Federico Gomez, Analyst, ATB Capital Market: the prepared remarks, correct me if I'm wrong.
Andrew Sample, Analyst, Vantum Financial: Can you sustain yields at this higher level or was Q4 a bit of an anomaly from that perspective?
Sam Brill, Director and Chief Executive Officer, Ascent Wellness Holdings: No, I would I want continued improvement. Like the average price per gram in this industry continues to come down, especially in the less mature markets. And if we're going to be competitive and we're going to be able to maintain our margins or improve them, we're going to have to improve our yields and volume that we can produce from those facilities. It's a key way that you can leverage the fixed cost assets. So there's opportunity, I think, I mean, well, look, it was a great achievement.
So I don't want to belittle that. I'm very proud of the team. But there are a lot of things that we still have not implemented that I think will continue to help drive those metrics and we should see improvements over time. I think in Canada, they have some of the highest average grams per square foot. So to me, like we there's no reason why we can't get there ourselves.
Andrew Sample, Analyst, Vantum Financial: Great. That's helpful. And maybe if you could spend some time talking about wholesale revenues and that expectations for that segment of the business in 2025. Obviously, you're doing what you can to improve cultivation yields and introducing new SKUs and brands. So that should be a positive for the wholesale business.
On the other hand, you're also going to be opening more of your own stores and partner stores and those stores are going to need supply and I imagine a sense wholesale or cultivation facilities will be supplying a fair bit of that. So maybe if you could answer whether you think you have the capacity to service those stores while maintaining and even growing your existing wholesale revenues or whether you're going to have to be a little bit more picky with how you allocate your supply going forward?
Sam Brill, Director and Chief Executive Officer, Ascent Wellness Holdings: When I look at the long term objectives, I think that when you have a fixed cost asset, the key is to drive as much volume through it as you can. And so the only way we're going to be able to sell all that volume is if we have competitive CPG brands, which I think we're doing a great job of improving, because the reality is our company has been producing really high quality products, but we've been putting it in packages that just frankly don't reflect what's in them. I know that sounds sort of like I think just we grew very fast, right? And so these are just things that kind of happened. But now we're taking that step back.
We have to think like a CPG company and have the products reflect what's in like the packaging reflect what's in them. So that's a key driver of what's going to we need the pull on both sides. We need it on the wholesale side, but we also want to control as much of as we can from the retail side. So it kind of it's a nice balanced business, but we need to do well on both sides, right? We have to be really good retailers and be consumer centric.
But the consumer centric part also flows through on the CPG side. We have to create products that are competitive, innovative and things that consumers want. And that's what we're focused on. That's what these refresh SKUs look like and that's what some of these new product launches are going to continue to look like. And we're going to try to be a leader in every one of our markets when it comes to that innovation and production.
So that's the way we see the best use of that fixed asset to drive returns for shareholders.
Andrew Sample, Analyst, Vantum Financial: Okay. Thank you for that, Sam, and congrats again on the quarter. I'll get back into queue.
Sam Brill, Director and Chief Executive Officer, Ascent Wellness Holdings: Sure. Thank you.
Operator: Thank you.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Written By: Investing.com
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.